Panel votes unanimously that Alzheimer’s drug offers no benefits – STAT



[ad_1]

  1. Panel votes unanimously that Alzheimer’s drug does not offer benefitsSTAT
  2. The FDA “abandoned its responsibility” by approving the drug Biogen Alzheimer: doctorYahoo finance
  3. Ohio clinic says it will not administer Alzheimer’s drug to patientsThe New York Times
  4. US review of drug Biogen Alzheimer could have been better handled – FDA chiefReuters
  5. Mount Sinai decides not to use controversial Alzheimer’s drugCBS New York
  6. See full coverage on Google News

[ad_2]

Source link